FINAL RESULTS OF A RANDOMIZED PHASE III TRIAL COMPARING FOLFIRINOX (F: 5FU/LEUCOVORIN [LV], IRINOTECAN [I] AND OXALIPLATIN [O]) VS GEMCITABINE (G) AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA (MPA). THE PRODIGE 4/ACCORD 11 TRIAL
ANNALS OF ONCOLOGY（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined